Obesity Clinical Trial
— ALPROsoyaOfficial title:
Vegetarian High Protein Weight Loss Diets
| Verified date | March 2014 |
| Source | University of Aberdeen |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United Kingdom: National Health Service |
| Study type | Interventional |
This study aims to investigate the mechanistic processes involved in protein-induced
satiety/satiation during weight loss in humans.
Thsi study will investigate:
- How do high-protein weight loss (HPWL) diets rich in meat or soya based protein sources
impact on profile of 'motivation to eat' both within a day and between days ?
- Do biomarkers of satiety alter differentially on meat or soya HPWL diet, as measured by
monitoring alteration in plasma amino acids and gut-related hormones ?
- How does a vegetarian and meat-based weight loss diet impact on nitrosamine excretion
in faecal samples, as an indicator of faecal toxicity?
Previous work has indicated that high-protein (30% protein) weight loss diets are more
satiating (produce less hunger) than normal protein WL diet (15% protein) or a diet
supplemented with few amino acids. In previous work, a mixed source of protein has been
used, mainly from meat (beef, chicken, fish). These types of diets have been criticised
because of the potential negative side effects, including our own work on gut health. It
might be that alternative vegetable sources of protein could fulfil the diet remit, to be
satiating and yet still allow weight loss, and maintain a healthy gut.
Design -within subject, randomised cross-over design after day 3. Each subject acts as their
own control and will receive each treatment. 18-20 subjects to participate.
Length of time - Conduct the two nutritional interventions over a period of 14 days, in
order to reduce effects due to an acute change in nutritional intake.
PROTOCOL Days 1- 3 - Normal Protein Maintenance diet (NP- MTD, 3 days)
1. st ARM Days 4-17 - randomised to High Protein-Weight loss-Meat (HP-Soya,14 days),
2. nd ARM Days 18-31 - randomised to High Protein-Weight loss-Soya (HP-meat,14 days),
| Status | Completed |
| Enrollment | 20 |
| Est. completion date | December 2010 |
| Est. primary completion date | December 2010 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | Male |
| Age group | 18 Years to 65 Years |
| Eligibility |
Inclusion Criteria: - Male - Overweight or obese (BMI 27+ ) - With no existing medical conditions or medication that could influence appetite or mood. Exclusion Criteria: - Diabetes - Severe gastrointestinal disorders - Kidney disease - Thromboembolic or coagulation disease - Hepatic disease - Alcohol or any other substance abuse - Gout - Eating disorders - Food allergy - Unregulated thyroid disease - Psychiatric disorders (including severe depression, lithium treatment, schizophrenia, severe behavioural disorders) |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Rowett Institute of Nutrition and Health, University of Aberdeen | Aberdeen |
| Lead Sponsor | Collaborator |
|---|---|
| University of Aberdeen |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Other | Weight loss | The subjects visited the Human Nutrition Unit at the Rowett Institute of Nutrition and Health (RINH), Aberdeen, United Kingdom daily for the weight measurement, after voiding, while wearing only a previously weighed dressing gown, to the nearest 100 g on a digital scale (DIGI DS-410; CMS Weighing Equipment, London, United Kingdom). | Every day of the study from day 1 to 32 inclusive | No |
| Primary | appetite control | Motivation to eat (VAS) hourly during waking hours up to 6pm in the evening, collected on a hand-help computer Food diary End of day questionnaire on mood |
Every day of the study: From day 1 to 32 inclusive | No |
| Secondary | Satiety biomarkers- COMPOSITE MEASURE | Subjects will undergo a nutritional challenge on days 4, 18 and 32, where they will attend the Human Nutrition Unit for a meal test (breakfast and lunch, separated by a 5 hr interval) with frequent blood sampling from a cannulae in the arm/hand. Total blood sample collection on each test day will be no more than 120ml per session, collected between 8am and 1pm. Blood samples will be used to measure plasma amino acid concentration, metabolites (e.g. lipids, glucose) and hormones relating to appetite (e.g. PYY). The meal test will consist of their standard meal from their menu. Body composition by bod pod, skinfolds and circumferences Two questionnaires - TFEI (Three-Factor Eating Inventory questionnaire)and DEBQ (Dutch Eating Behaviour) to assess influences on eating Resting metabolic rate using ventilated hood Blood pressure and pulse |
test day (day 1, 4, 18, 32 of the study) | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
| Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
| Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
| Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
| Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
| Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
| Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
| Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
| Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
| Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
| Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
| Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
| Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
| Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
| Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
| Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
| Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
| Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
| Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |